Tanigawara Y - Search Results

1

Development of an S-1 dosage formula based on renal function by a prospective pharmacokinetic study.

Booka E, Imamura CK, Takeuchi H, Hamamoto Y, Gomi D, Mizukami T, Ichiyama T, Tateishi K, Takahashi T, Kawakubo H, Soejima K, Boku N, Tanigawara Y, Kitagawa Y. Booka E, et al. Among authors: tanigawara y. Gastric Cancer. 2016 Jul;19(3):876-86. doi: 10.1007/s10120-015-0536-6. Epub 2015 Aug 25. Gastric Cancer. 2016. PMID: 26304171 Free PMC article.

2

Prospective evaluation and refinement of an S-1 dosage formula based on renal function for clinical application.

Takeuchi M, Imamura CK, Booka E, Takeuchi H, Mizukami T, Kawakami T, Funakoshi T, Wakuda K, Aoki Y, Hamamoto Y, Kitago M, Kawakubo H, Boku N, Tanigawara Y, Kitagawa Y. Takeuchi M, et al. Among authors: tanigawara y. Cancer Sci. 2021 Feb;112(2):751-759. doi: 10.1111/cas.14758. Epub 2021 Jan 6. Cancer Sci. 2021. PMID: 33277781 Free PMC article. Clinical Trial.

3

Evaluation of clinical validity of an S-1 dosage formula based on renal function using data of the SPIRITS and the G-SOX trials.

Booka E, Imamura CK, Takeuchi M, Kawakubo H, Takeuchi H, Tanigawara Y, Kitagawa Y, Boku N. Booka E, et al. Among authors: tanigawara y. Gastric Cancer. 2022 Jul;25(4):770-782. doi: 10.1007/s10120-022-01291-z. Epub 2022 Mar 31. Gastric Cancer. 2022. PMID: 35357635

4

Individualized Dosing of Axitinib Based on First-Dose Area Under the Concentration-Time Curve for Metastatic Renal-Cell Carcinoma.

Miura Y, Imamura CK, Uchino K, Kishida T, Matsubara N, Shinojima T, Kondo K, Hongo F, Yoshimura K, Tanigawara Y, Takano T. Miura Y, et al. Among authors: tanigawara y. Clin Genitourin Cancer. 2019 Feb;17(1):e1-e11. doi: 10.1016/j.clgc.2018.09.015. Epub 2018 Sep 29. Clin Genitourin Cancer. 2019. PMID: 30529389 Clinical Trial.

5

Impact of cytochrome P450 2C19 polymorphisms on the pharmacokinetics of tacrolimus when coadministered with voriconazole.

Imamura CK, Furihata K, Okamoto S, Tanigawara Y. Imamura CK, et al. Among authors: tanigawara y. J Clin Pharmacol. 2016 Apr;56(4):408-13. doi: 10.1002/jcph.605. Epub 2015 Oct 8. J Clin Pharmacol. 2016. PMID: 26239045 Free PMC article. Clinical Trial.

6

Application of PBPK Modeling and Virtual Clinical Study Approaches to Predict the Outcomes of CYP2D6 Genotype-Guided Dosing of Tamoxifen.

Nakamura T, Toshimoto K, Lee W, Imamura CK, Tanigawara Y, Sugiyama Y. Nakamura T, et al. Among authors: tanigawara y. CPT Pharmacometrics Syst Pharmacol. 2018 Jul;7(7):474-482. doi: 10.1002/psp4.12307. Epub 2018 Jun 19. CPT Pharmacometrics Syst Pharmacol. 2018. PMID: 29920987 Free PMC article.

7

The effects of advanced age and serum α₁ -acid glycoprotein on docetaxel unbound exposure and dose-limiting toxicity in cancer patients.

Kenmotsu H, Imamura CK, Ono A, Omori S, Nakashima K, Wakuda K, Taira T, Naito T, Murakami H, Takahashi T, Tanigawara Y. Kenmotsu H, et al. Among authors: tanigawara y. Br J Clin Pharmacol. 2017 Nov;83(11):2416-2425. doi: 10.1111/bcp.13354. Epub 2017 Aug 17. Br J Clin Pharmacol. 2017. PMID: 28640540 Free PMC article.

8

[Appropriate hemodialysis scheduling based on therapeutic drug monitoring of carboplatin in a patient with lung cancer and chronic renal failure].

Kamata H, Asano K, Soejima K, Shirahata T, Nakatani M, Inamoto H, Iketani O, Yamayoshi Y, Tanigawara Y, Ishizaka A. Kamata H, et al. Among authors: tanigawara y. Gan To Kagaku Ryoho. 2009 Sep;36(9):1529-32. Gan To Kagaku Ryoho. 2009. PMID: 19755826 Japanese.

9

Effect of everolimus on the glucose metabolic pathway in mouse skeletal muscle cells (C2C12).

Yoshida K, Imamura CK, Hara K, Mochizuki M, Tanigawara Y. Yoshida K, et al. Among authors: tanigawara y. Metabolomics. 2017;13(8):98. doi: 10.1007/s11306-017-1236-5. Epub 2017 Jul 7. Metabolomics. 2017. PMID: 28781589 Free PMC article.

10

Evaluation of gefitinib systemic exposure in EGFR-mutated non-small cell lung cancer patients with gefitinib-induced severe hepatotoxicity.

Kawamura T, Imamura CK, Kenmotsu H, Taira T, Omori S, Nakashima K, Wakuda K, Ono A, Naito T, Murakami H, Mushiroda T, Takahashi T, Tanigawara Y. Kawamura T, et al. Among authors: tanigawara y. Cancer Chemother Pharmacol. 2020 Mar;85(3):605-614. doi: 10.1007/s00280-020-04034-y. Epub 2020 Feb 10. Cancer Chemother Pharmacol. 2020. PMID: 32040702

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

165 results

Search Page